Literature DB >> 16301596

Acute chemotherapy-induced cardiovascular changes in patients with testicular cancer.

Janine Nuver1, Andries J Smit, Jan van der Meer, Maarten P van den Berg, Winette T A van der Graaf, Martin T Meinardi, Dirk Th Sleijfer, Harald J Hoekstra, Anne I van Gessel, Arie M van Roon, Jourik A Gietema.   

Abstract

PURPOSE: After cisplatin- and bleomycin-containing chemotherapy for testicular cancer, part of the patient population will develop acute or long-term cardiovascular toxicity. It is largely unknown whether standard tests can be used to assess chemotherapy-induced cardiovascular changes. PATIENTS AND METHODS: In 65 testicular cancer patients (median age, 27 years; range, 18 to 48 years), we measured the following cardiovascular parameters before and within 10 weeks after completion of cisplatin-based chemotherapy: platelet numbers, plasma levels of hemostatic and fibrinolytic factors, 24-hour ambulatory blood pressure, baroreflex sensitivity, intima-media thickness of the common carotid artery, and flow-mediated vasodilation of the brachial artery.
RESULTS: Compared with prechemotherapy values, the intima-media thickness of the carotid artery and plasma von Willebrand factor levels increased significantly after treatment. Platelet numbers and plasma levels of other hemostatic and fibrinolytic factors did not appear to change significantly. Blood pressure decreased significantly, but flow-mediated vasodilation and baroreflex sensitivity did not change.
CONCLUSION: In testicular cancer patients treated with cisplatin-based chemotherapy, we found an increase in plasma von Willebrand factor levels and in the intima-media thickness of the carotid artery. These changes may indicate chemotherapy-induced vascular damage and be of prognostic significance for the development of cardiovascular complications in the long term.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16301596     DOI: 10.1200/JCO.2005.01.4092

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  53 in total

1.  Primary percutaneous coronary intervention and intravascular ultrasound imaging for coronary thrombosis after cisplatin-based chemotherapy.

Authors:  Daisuke Ito; Jun Shiraishi; Takeshi Nakamura; Naoki Maruyama; Yumi Iwamura; Sho Hashimoto; Masayoshi Kimura; Akihiro Matsui; Hirokazu Yokoi; Masayasu Arihara; Hidekazu Irie; Masayuki Hyogo; Takatomo Shima; Yoshio Kohno; Akiyoshi Matsumuro; Takahisa Sawada; Hiroaki Matsubara
Journal:  Heart Vessels       Date:  2012-01-05       Impact factor: 2.037

2.  Metabolic syndrome in childhood leukemia survivors: a meta-analysis.

Authors:  Maria Felicia Faienza; Maurizio Delvecchio; Paola Giordano; Luciano Cavallo; Maria Grano; Giacomina Brunetti; Annamaria Ventura
Journal:  Endocrine       Date:  2014-08-26       Impact factor: 3.633

3.  Treatment-related differences in cardiovascular risk factors in long-term survivors of testicular cancer.

Authors:  T Wethal; J Kjekshus; J Røislien; T Ueland; A K Andreassen; R Wergeland; P Aukrust; S D Fosså
Journal:  J Cancer Surviv       Date:  2007-03       Impact factor: 4.442

4.  Antitumour and antiangiogenic activities of [Pt(O,O'-acac)(γ-acac)(DMS)] in a xenograft model of human renal cell carcinoma.

Authors:  A Muscella; C Vetrugno; F Biagioni; N Calabriso; M T Calierno; F Fornai; S A De Pascali; S Marsigliante; F P Fanizzi
Journal:  Br J Pharmacol       Date:  2016-07-22       Impact factor: 8.739

5.  Chemotherapy-induced vascular toxicity--real-time in vivo imaging of vessel impairment.

Authors:  Hadas Bar-Joseph; Salomon Marcello Stemmer; Ilan Tsarfaty; Ruth Shalgi; Irit Ben-Aharon
Journal:  J Vis Exp       Date:  2015-01-07       Impact factor: 1.355

6.  Cortical blindness due to cerebral infarct in advanced pancreatic cancer.

Authors:  Nivedita Nimesh; Sanjeev Kumar Verma; Sanjiv Kumar Gupta
Journal:  BMJ Case Rep       Date:  2019-08-01

Review 7.  Cardio-oncology: a new and developing sector of research and therapy in the field of cardiology.

Authors:  Peggy M Kostakou; Nikos T Kouris; Vassilios S Kostopoulos; Dimitrios S Damaskos; Christoforos D Olympios
Journal:  Heart Fail Rev       Date:  2019-01       Impact factor: 4.214

8.  [Results of the randomised phase III study of the German Testicular Cancer Study Group. Retroperitoneal lymphadenectomy versus one cycle BEP as adjuvant therapy for non-seminomatous testicular tumours in clinical stage I].

Authors:  M Hartmann; R Siener; S Krege; H Schmelz; K-P Dieckmann; A Heidenreich; P Kwasny; M Pechoel; J Lehmann; S Kliesch; K-U Köhrmann; R Fimmers; L Weissbach; V Loy; C Wittekind; P Albers
Journal:  Urologe A       Date:  2009-05       Impact factor: 0.639

9.  Thrombosis of abdominal aorta during cisplatin-based chemotherapy of testicular seminoma - a case report.

Authors:  Klaus-Peter Dieckmann; Ralf Gehrckens
Journal:  BMC Cancer       Date:  2009-12-22       Impact factor: 4.430

10.  Evaluation of sub-acute changes in cardiac function after cisplatin-based combination chemotherapy for testicular cancer.

Authors:  R Altena; E C de Haas; J Nuver; C A J Brouwer; M P van den Berg; A J Smit; A Postma; D Th Sleijfer; J A Gietema
Journal:  Br J Cancer       Date:  2009-05-19       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.